Trial watch: Phase III success for novel Clostridium difficile antibiotic.
D000328:Adult; D000900:Anti-Bacterial Agents / Q000494:pharmacology / Q000627:therapeutic use*; D017326:Clinical Trials, Phase III as Topic; D016360:Clostridioides difficile / Q000187:drug effects / Q000302:isolation & purification; D003015:Clostridium Infections / Q000188:drug therapy* / Q000382:microbiology; D006027:Glycosides / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D012008:Recurrence
D000900:Anti-Bacterial Agents; D006027:Glycosides; C487655:OPT 80